Cardio Diagnostics Holdings, Inc. financial data

Symbol
CDIO, CDIOW on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
311 W. Superior Street, Suite 444, Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Former names
Mana Capital Acquisition Corp. (to 10/26/2022)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 247 %
Debt-to-equity 65.1 % +13.8%
Return On Equity -309 % -81.8%
Return On Assets -187 % -376%
Operating Margin -21.5K % +92.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.9M shares +103%
Common Stock, Shares, Outstanding 23.3M shares +109%
Entity Public Float 9.4M USD -85.4%
Common Stock, Value, Issued 233 USD +108%
Weighted Average Number of Shares Outstanding, Basic 22.6M shares +121%
Weighted Average Number of Shares Outstanding, Diluted 22.6M shares +121%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 39.1K USD +1363%
Research and Development Expense 64.3K USD -51.7%
Selling and Marketing Expense 170K USD +36%
General and Administrative Expense 8.21M USD +9.32%
Operating Income (Loss) -8.43M USD -8.16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.77M USD -2.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.77M USD -2.2%
Earnings Per Share, Basic -0.42 USD/shares +76.4%
Earnings Per Share, Diluted -0.42 USD/shares +76.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD
Accounts Receivable, after Allowance for Credit Loss, Current 7.52K USD +616%
Assets, Current 2.14M USD -65.8%
Property, Plant and Equipment, Net 720K USD +2668%
Operating Lease, Right-of-Use Asset 575K USD 0%
Assets 4M USD -40.8%
Accrued Liabilities, Current 1.98K USD
Liabilities, Current 376K USD
Operating Lease, Liability, Noncurrent 663K USD 0%
Liabilities 923K USD -76%
Retained Earnings (Accumulated Deficit) -19.8M USD -79.4%
Stockholders' Equity Attributable to Parent 3.07M USD +5.7%
Liabilities and Equity 4M USD -40.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.23M USD +25.2%
Net Cash Provided by (Used in) Financing Activities 1.58M USD -63.1%
Net Cash Provided by (Used in) Investing Activities -69.9K USD -32.8%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 23.3M shares +109%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.31M USD -74%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.82K USD -34.4%
Deferred Tax Assets, Valuation Allowance 4.71M USD +162%
Deferred Tax Assets, Gross 4.71M USD +162%
Operating Lease, Liability 777K USD +20.9%
Depreciation 36K USD
Payments to Acquire Property, Plant, and Equipment 20K USD
Lessee, Operating Lease, Liability, to be Paid 836K USD
Operating Lease, Liability, Current 224K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 261K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 129K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 58.8K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 250K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.22M USD +162%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102K USD
Operating Lease, Payments 64.1K USD
Additional Paid in Capital 22.9M USD +64.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 678K USD -99.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%